126 Views
Sunday Poster Session
Category: Esophagus
Ravy K. Vajravelu, MD, MSCE
University of Pittsburgh School of Medicine
Pittsburgh, PA, United States
Total GERD cohort | GERD diagnosed by a non-GI provider | GERD diagnosed by a GI provider | |
n = 1,549,553 | n = 1,391,537 | n = 158,016 | |
Demographics |
|
|
|
Age (%) |
|
|
|
18-29 | 9.7 | 9.8 | 8.3 |
30-39 | 14.0 | 14.2 | 11.9 |
40-49 | 18.0 | 18.1 | 16.3 |
50-59 | 19.1 | 18.5 | 24.6 |
60-69 | 19.0 | 18.7 | 21.1 |
70-79 | 14.2 | 14.3 | 13.9 |
80+ | 6.1 | 6.3 | 3.9 |
Female (%) | 56.4 | 56.3 | 58.1 |
Race/ethnicity (%) |
|
|
|
Asian | 3.8 | 3.8 | 4.5 |
Black | 9.6 | 9.7 | 9.2 |
Hispanic | 10.0 | 9.7 | 12.1 |
Unknown | 11.1 | 11.1 | 11.1 |
White | 65.5 | 65.7 | 63.2 |
Total follow-up (mean years) | 5.6 | 5.6 | 5.6 |
Enrollment to GERD diagnosis (mean years) | 2.4 | 2.5 | 2.4 |
Charlson-Deyo score (mean) | 1.9 | 1.9 | 1.9 |
High-dimensional utilization score (mean) | 1.7 | 1.7 | 1.7 |
Upper gastrointestinal malignancy risk factors/signs (%) |
|
|
|
Family history of gastrointestinal cancer | 1.1 | 1.1 | 1.1 |
Helicobacter pylori infection | 0.1 | 0.1 | 0.2 |
Iron deficiency anemia | 7.3 | 7.0 | 9.9 |
Obesity | 9.1 | 9.1 | 9.0 |
Tobacco use | 8.6 | 8.6 | 8.1 |
Gastrointestinal signs/symptoms (%) |
|
|
|
Abdominal pain | 8.0 | 6.3 | 23.4 |
Diarrhea | 1.7 | 1.0 | 7.4 |
Dysphagia | 0.0 | 0.0 | 0.0 |
Nausea/vomiting | 2.1 | 1.6 | 5.9 |
Melena/rectal bleeding | 1.6 | 0.7 | 9.4 |
Weight loss | 0.6 | 0.4 | 1.7 |